ELVN - Enliven Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$75.14
DETAILS
HIGH:
$82.00
LOW:
$65.00
MEDIAN:
$78.00
CONSENSUS:
$75.14
UPSIDE:
101.34%
Metrics Summary
Market Cap:
2.73B
Volume:
1,188,421
Avg Volume:
1,435,546
52 Week Range:
14.785-62.32
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.24
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
67
IPO Date:
2020-03-12